Shoichi Deguchi
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Pituicytoma in the third ventricle suggesting a third ventricular floor origin: illustrative case.
Journal: Journal of neurosurgery. Case lessons
Published: April 26, 2026
Physiological biodistribution of 18F-fluciclovine PET in the head: as a baseline for interpretation in patients with suspected glioma.
Journal: Frontiers in nuclear medicine
Published: April 08, 2026
Feasibility of perampanel monotherapy for seizure management during awake craniotomy for glioma.
Journal: Journal of neuro-oncology
Published: March 10, 2026
Real-time PCR-based intraoperative molecular boundary diagnosis of corticotroph pituitary neuroendocrine tumors.
Journal: Journal of neuroscience methods
Published: February 17, 2026
Genomic Alteration Patterns Across Histological Grades in BRAF p.V600E-Mutant Gliomas and Glioneuronal Tumors: An Analysis of 15 Cases.
Journal: Pathology international
Published: February 15, 2026
Efficacy and safety of multimodality therapy stratified by resection rate and molecular markers in children and adolescents with ependymoma: JCCG EPN23 protocol.
Journal: Japanese journal of clinical oncology
Published: January 18, 2026
Prognostic significance of CDKN2A/B hemizygous deletion in IDH-mutant astrocytomas: a systematic review and meta-analysis.
Journal: Brain tumor pathology
Published: November 17, 2025
Rapid intraoperative boundary diagnosis of somatotroph pituitary neuroendocrine tumors using real-time PCR.
Journal: Acta neuropathologica communications
Published: October 05, 2025
Pressure-composition phase diagram of diblock copolymers.
Journal: The Journal of chemical physics
Published: September 30, 2025
Prognostic implication of CDKN2A/B homozygous deletion on histological grades in isocitrate dehydrogenase-mutant astrocytomas: A systematic review and meta-analysis.
Journal: Neuro-oncology advances
Published: September 22, 2025
Rapid intraoperative genetic analysis of adult-type diffuse gliomas using a microfluidic real-time polymerase chain reaction device.
Journal: Neuro-oncology
Published: August 25, 2025
Relation between tumor treating fields usage rate ≥75% for the first 3 months and progression-free survival in patients with newly diagnosed WHO grade 4 gliomas.
Journal: Neuro-oncology advances
Published: June 06, 2025
Last Updated: 09/26/2026